We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The government of the Philippines has entered into an agreement with Interphil Laboratories, a local subsidiary of the Zuellig Group, for the manufacture and distribution of low-cost generic drugs.
Health officials have warned that the number of people seeking medical assistance for diabetes in West Africa has shot up in recent years but that programs for treatment have not expanded accordingly, the UN Integrated Regional Information Networks (IRIN) reports.
Merck expects its drug development pipeline, including three expected new drug applications (NDAs) in 2007, to contribute to high earnings growth, the company announced.
New vaccines against the virus that causes cervical cancer could save hundreds of thousands of women's lives in the developing world, home to the vast majority of the more than 250,000 women who died from the disease last year, and funding to make them available must be a priority, United Nations health officials said yesterday at a conference in London.
Indian drugmaker Aurobindo Pharma announced it has received marketing authorization from Medicines Evaluation Board of the Netherlands for its generic simvastatin tablets, 5, 10, 20, 40 and 80 mg.
Generic drugmaker Novopharm, a Canadian subsidiary of Teva Pharmaceutical, will have to wait at least three years before it can grab a piece of the multi-billion-dollar Lipitor market, a court has ruled.
Beijing Med-Pharm, a drug marketing and distribution company, announced it has entered into a master services agreement with Cephalon under which Beijing Med-Pharm will complete the clinical development and registration process for certain Cephalon products in China.
The Treatment Action Campaign (TAC), a South African organization, has issued a statement saying that its settlement agreements with drugmakers GlaxoSmithKline (GSK) and Boehringer Ingelheim to license generic antiretrovirals are unaffected by a recent court ruling amending another agreement involving the companies.